University Of Sheffield Home Page

    Home Services Staff Research Inforrmation

Information For:

» Staff
» Patients
» Health Professionals
Home > Information > Information for Patients > Pleural Disease

Information for Patients

What is Interstitial Lung Disease?

The interstitial lung diseases (ILD) are a varied group of conditions that mainly affect the lung tissue itself rather than the airways (breathing tubes). They cause both inflammation and scarring of the lung, the latter also known as fibrosis. These diseases are often first picked up on a chest x-ray, perhaps performed because of shortness of breath or a troublesome dry cough. Occasionally the diagnosis is made because patients have manifestations of other, more generalised conditions such as sarcoidosis, rheumatoid arthritis or a connective tissue disease.

Patients referred for investigation of possible ILD will typically have initial investigations that include blood tests and a CT scan, to give clues to the cause of lung scarring, and breathing tests to assess the extent to which the function of their lungs is being affected. In order to make a definite diagnosis of the cause, we may have to perform additional investigations such as bronchoscopy and sometimes a surgical lung biopsy. These investigations are important in reaching a diagnosis, making treatment decisions and also in giving patients information about their prognosis.


The commonest interstitial lung disease (ILD) is fibrosing alveolitis, sometimes called “cryptogenic” because its cause is unknown, and also called idiopathic pulmonary fibrosis. An apparently identical condition also occurs as a complication of rheumatoid arthritis. A similar condition can be found in connective tissue diseases, particularly scleroderma. There are approximately 2,500 new diagnoses each year so that, although not rare, patients tend to be referred to clinicians who have an interest n this disease and who are used to treating it. Fibrosing alveolitis is difficult to treat although a number of newer drugs are becoming available and some are entering clinical trials soon. Further information on this condition is available from the British Lung Foundation and from European Lung Foundation.

The other common ILD is a condition called sarcoidosis. Again the cause is unknown but it can affect many different parts of the body including the skin, lymph glands and sometimes the lung. In general, sarcoidosis can be treated successfully especially if diagnosed early but a small number of patients do develop significant lung scarring. Again, more information can be obtained from The British Lung Foundation.

There are many rarer forms of ILD. In the ILD Clinic the doctors and respiratory nurse specialists will give patients full information about their condition to help then to understand what it means and explain the rationale for their investigations and treatment.

The British Thoracic Society and the British Lung Foundation have excellent websites with extensive patient information, and where appropriate information cannot be found here we suggest you look at these sites.

NHS Sheffield